Emerging Researchers National (ERN) Conference

nsf-logo[1]

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Registration
    • Conference Registration
    • Exhibitor Registration
    • Hotel Reservations
  • Abstracts
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
    • Undergraduate Abstract Locator (2020)
    • Graduate Abstract Locator (2020)
    • Faculty Abstract Locator (2020)
  • Travel Awards
  • Resources
    • App
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • Video Contest
    • Video Contest Winners
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • App View

Development of Novel Tetrahydroimidazopyridine and their Antiproliferative Property Against Prostate Cancer

Undergraduate #160
Discipline: Chemistry and Chemical Sciences
Subcategory: Cancer Research

Dontá Samuel - Clark Atlanta University
Co-Author(s): Idris Wazeerud-Din and Xiu R. Bu, Clark Atlanta University, Atlanta, GA



Many drugs contain imidazole moiety, and likewise, many imidazole compounds have important biological properties. The development of imidazole derivatives becomes a part of efforts in the cancer drug discovery research. We have previously developed novel classes of imidazopyridines (IMP) and also demonstrated that they possess promising antiproliferative properties against castration-resistant prostate cancer cells. Here we extend our study to the reduced form of imidazopyridine to prepare a new class of tetrahydroimidazopyridines (THIP). THIP consists of a five-membered imidazole ring fused with a six-membered heterocyclic piperidine ring. The difference between THIP and IMP is that THIP has piperidine ring while IMP has pyridine ring instead. This new structural feature offers us an opportunity to explore unique property against prostate cancer cells. Currently, we have developed several THIPs through the reduction of IMPs. One of the compound, 1,3-diphenyltetrahydroimidazopyridine has been evaluated for antiproliferative property. It has displayed promising effectiveness against prostate cancer cell lines (PC3). Our goal of this project is to optimize the condition to synthesize novel THIP derivatives, then create a library of compounds for the structural investigation of their antiproliferative properties against PC3 cells.

Funder Acknowledgement(s): CCRTD, LSAMP, and NSF

Faculty Advisor: James Bu, Jbu@cau.edu

Role: Characterization of the imidazopyridine and using nmr (nuclear magnetic resonance) to show the sifts of the THIP. Basically the bulk of my abstract was my research.

ERN Conference

Celebrating 10 years of ERN!

What’s New

  • Webinars
  • Events|Opportunities
  • AAAS CEO Comments on Social Unrest, Racism, and Inequality
  • Maintaining Accessibility in Online Teaching During COVID-19
  • In the News
  • #ShutDownSTEM
  • HBCU/CREST PI/PD Meeting

Conference Photos

ERN Conference Photo Galleries

Awards

ERN Conference Award Winners

Checking In

Navigation

  • About the ERN Conference
  • Partners/Supporters
  • Abstracts
  • Travel Awards
  • Conference Registration
  • Exhibitor Registration
  • Hotel Reservations

nsf-logo[1]

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW Washington,DC 20005
202-326-6400
Contact Us
About Us

The World's Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

 

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law
© 2021 American Association for the Advancement of Science